CRONOS GROUP INC. Noncontrolling Interest, Increase from Subsidiary Equity Issuance
CRONOS GROUP INC. (CRON) reported Noncontrolling Interest, Increase from Subsidiary Equity Issuance of $83.07 million for the 12-month period ending 2019-12-31, per its 10-K filed 2022-03-01.
Discontinued › Shareholders' Equity
us-gaap:NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance · last filed 2022-03-01
- CRONOS GROUP INC. noncontrolling interest, increase from subsidiary equity issuance for fiscal 2019 was $83.07M, a 28845.30% increase from fiscal 2018.
- CRONOS GROUP INC. noncontrolling interest, increase from subsidiary equity issuance for fiscal 2018 was $287.00K.
| Period end | Noncontrolling Interest, Increase from Subsidiary Equity Issuance 12 month |
|---|---|
| 2019-12-31 | $83.07M 10-K · filed 2022-03-01 |
| 2018-12-31 | $287.00K 10-K · filed 2021-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |